Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECOND-LINE study
2009-012283-14Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Kaletra + N(t)RTI backbone with Kaletra + Isentress (2 arms). Started Feb 2010; status: completed.
02
Drugs
lopinavir + ritonavirraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-012283-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012283-14.